| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 2,208,000 | 1,929,000 | 1,591,000 | 1,824,000 | | Cost of Revenue | 1,694,000 | 1,559,000 | 1,338,000 | 1,534,000 | | | Gross Profit | 514,000 | 370,000 | 253,000 | 290,000 | | | Operating Expenses | | Research Development | 142,000 | 132,000 | 125,000 | 119,000 | | Selling General and Administrative | 53,000 | 52,000 | 50,000 | 42,000 | | Non Recurring |
-
| (23,000) | 18,000 | 113,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 319,000 | 209,000 | 60,000 | 16,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 1,000 | 2,000 | 2,000 | | Earnings Before Interest And Taxes | 320,000 | 210,000 | 62,000 | 18,000 | | Interest Expense | 3,000 | 3,000 | 5,000 | 11,000 | | Income Before Tax | 317,000 | 207,000 | 57,000 | 7,000 | | Income Tax Expense | 29,000 | 11,000 | 8,000 | (7,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 288,000 | 196,000 | 49,000 | 14,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 288,000 | 196,000 | 49,000 | 14,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $288,000 | $196,000 | $49,000 | $14,000 |
|
0.08% Nasdaq 
0.15%
Income Statement
